SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-080495
Filing Date
2011-03-29
Accepted
2011-03-29 06:55:38
Documents
8
Period of Report
2011-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 28998
2 FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES C dex45.htm EX-4.5 71759
3 OPINION OF ARENA'S GENERAL COUNSEL dex51.htm EX-5.1 4756
4 SECURITIES PURCHASE AGREEMENT dex991.htm EX-99.1 80574
5 SECOND AMENDMENT TO FACILITY AGREEMENT dex992.htm EX-99.2 27863
6 EXCHANGE AGREEMENT dex993.htm EX-99.3 60006
7 FORM OF WARRANT TO PURCHASE COMMON STOCK OF ARENA dex994.htm EX-99.4 127101
8 PRESS RELEASE ANNOUNCING OFFERING dex995.htm EX-99.5 6610
  Complete submission text file 0001193125-11-080495.txt   408813
Mailing Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6166 NANCY RIDGE DR SAN DIEGO CA 92121 8584537200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 11717291
SIC: 2834 Pharmaceutical Preparations